IRIS
DI STASI, SAVINO MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.954
EU - Europa 5.559
AS - Asia 5.194
SA - Sud America 882
AF - Africa 79
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
Totale 65.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 53.807
SG - Singapore 2.485
IT - Italia 1.311
CN - Cina 938
UA - Ucraina 813
FR - Francia 724
BR - Brasile 701
DE - Germania 668
RU - Federazione Russa 575
HK - Hong Kong 544
IE - Irlanda 485
VN - Vietnam 423
FI - Finlandia 270
KR - Corea 228
GB - Regno Unito 222
SE - Svezia 212
JP - Giappone 149
PL - Polonia 85
CA - Canada 78
IN - India 78
ID - Indonesia 75
AR - Argentina 60
NL - Olanda 56
BD - Bangladesh 46
MX - Messico 46
CL - Cile 39
IQ - Iraq 34
ES - Italia 31
TR - Turchia 30
ZA - Sudafrica 26
EC - Ecuador 24
PK - Pakistan 22
AT - Austria 19
EG - Egitto 16
PY - Paraguay 16
VE - Venezuela 15
IL - Israele 14
AU - Australia 13
CO - Colombia 13
CZ - Repubblica Ceca 13
EU - Europa 13
MA - Marocco 13
HU - Ungheria 12
MY - Malesia 12
PH - Filippine 12
TW - Taiwan 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
DK - Danimarca 10
TH - Thailandia 10
KG - Kirghizistan 9
GR - Grecia 8
IR - Iran 8
NP - Nepal 8
CH - Svizzera 7
SA - Arabia Saudita 7
AL - Albania 6
BE - Belgio 6
DZ - Algeria 6
PE - Perù 6
TN - Tunisia 6
JM - Giamaica 5
KE - Kenya 5
KW - Kuwait 5
RO - Romania 5
UY - Uruguay 5
HN - Honduras 4
JO - Giordania 4
BG - Bulgaria 3
GE - Georgia 3
KH - Cambogia 3
LT - Lituania 3
OM - Oman 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NR - Nauru 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
SM - San Marino 2
SN - Senegal 2
A1 - Anonimo 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
Totale 65.687
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.343
Wilmington 14.930
Houston 12.676
Singapore 1.370
Fairfield 1.221
Ashburn 783
Ann Arbor 730
Jacksonville 709
San Jose 614
Hong Kong 529
Dublin 479
Seattle 478
Chandler 463
Cambridge 399
Medford 372
Beijing 342
Santa Clara 241
Dearborn 239
Council Bluffs 183
Rome 177
Lawrence 174
The Dalles 139
New York 123
Los Angeles 120
Lauterbourg 118
Helsinki 117
Dallas 116
Moscow 113
Mülheim 113
Ho Chi Minh City 110
Tokyo 107
Buffalo 106
Hanoi 81
Milan 80
Menlo Park 76
Kraków 65
San Diego 61
São Paulo 61
Phoenix 58
Jakarta 56
Dong Ket 53
University Park 50
Chicago 49
Seongnam 41
Zhengzhou 41
London 40
Boardman 37
Nuremberg 37
Munich 32
Falls Church 31
Frankfurt am Main 30
Brooklyn 29
Redondo Beach 25
Guangzhou 23
Montreal 23
Rio de Janeiro 23
Naples 22
Seoul 22
Atlanta 21
Shanghai 21
Bologna 20
Hefei 19
Nanjing 19
Columbus 18
Curitiba 18
Norwalk 18
Redwood City 18
San Francisco 18
Toronto 18
Verona 18
Da Nang 17
Orem 17
Haiphong 16
Chennai 15
Florence 15
Temuco 15
Amsterdam 14
Kunming 14
Stockholm 14
Belo Horizonte 13
Johannesburg 13
North Bergen 13
Buenos Aires 12
Hangzhou 12
Jinan 12
Washington 12
Baghdad 11
Boston 11
Campinas 11
Catania 11
Kyiv 11
Mountain View 11
Salvador 11
Turin 11
Warsaw 11
Brno 10
Denver 10
Mexico City 10
Taipei 10
Tampa 10
Totale 56.479
Salva come PNG Salva come JPEG
Nome #
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm 811
L’ecocolor Doppler nella diagnosi di prostatite granulomatosa especifica: esperienza personale. 569
New Frontiers in Intravesical Therapies and Drug Delivery 541
Cisti intraparenchimali del didimo: aspetti ecografici. 541
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus calmette-guerin for non-muscle-invasive bladder cancer 532
Updates in intravesical electromotive drug administration(A (R)) of mitomycin-C for non-muscle invasive bladder cancer 529
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 526
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 505
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo 502
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder 495
The Nocturnal alarm as a conditioning therapy in primary nocturnal enuresis. 494
Metastasis-free survival is a strong Surrogate of overall survival in localized prostate cancer 486
L'Ecografia nella diagnosi dei diverticoli dell'uretra femminile. 485
Prevalence of chronic prostatitis in men with premature ejaculation. 485
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. 480
Concentration-depth profiles of mitomycin-C in the human bladder wall after passive diffusion, thermochemotherapy, and electromotive drug administration. 478
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study 468
Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens 464
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. 463
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. 462
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. 460
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. 458
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo. 451
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 448
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial 448
Pelvic floor muscle behavior during Valsalva leak point pressure measurement in males and females affected by stress urinary incontinence. 448
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study 447
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 447
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. 447
The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. 446
Electromotive delivery of mitomycin C into human bladder wall 445
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer 442
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass 440
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 440
Alfa-2a-interferon in neoadjuvant and adjuvant therapy of superficial ladder cancer: preliminary results. 440
Tissue pharmacokinetics of mitomycin-c in the human bladder wall after passive diffusion, thermo-chemotherapy and electromotive drug administration. 440
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. 439
Electromotive administration of oxybutynin into the human bladder wall. 438
Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial 435
The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. 434
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction. 431
Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells. 430
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys 427
Electromotive delivery of mitomycin C into human bladder wall 427
Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: a controlled prospective study. 426
Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies 426
La terapia intralesionale dei tumori superficiali a cellule transizionali della vescica con interferone alfa ricombinante 426
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin 425
Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. 421
Single preoperative intravesical instillation of electromotive mitomycin-c for primary non-muscle invasive bladder cancer: a prospective randomized trial. 421
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients 420
Single immediate preoperative intravesical instillation of electromotive mitomycin-C for low risk superficial bladder cancer: A prospective randomized study. 420
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study. 418
Adjuvant alpha-interferon in renal cell carcinoma at high risk of relapse. A multicentre pilot study. 418
Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography. 416
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. 415
The human bladder urothelium: new concepts and future perspectives. 413
Intravesical electromotive drug administration. 413
Intravesical electro-osmotic administration of mitomycin C 413
Urodynamic assessment of bladder and urethral sphincter function before radical prostatectomy and during long-term follow-up. 412
Diverticoli uretrali ed ascessi parauretrali nella donna: nostra esperienza. 412
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 411
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys. 408
The bladder urothelium: passive permeabilità and intravesical drug passive diffusion. 408
Intravesical sequential BCG and electromotive mitomycin versus BCG alone in high risk non-muscle invasive bladder cancer 408
Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer 408
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 404
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study 403
Tumori vescicali intradiverticolari. Diagnosi preoperatoria. 403
Intravesical electromotive administration of oxybutynin: from laboratoty to clinica field. 403
BCG nel carcinoma vescicale 403
Autonomic dysreflexia during urodynamics 402
Our experience with Epirubicin in the treatmnet of superficial bladder tumors after conservative therapy. 402
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 401
Contemporary management of non-muscle invasive bladder cancer at italian referral centres adopting eau guidelines 400
Percutaneous sequential bacillus Calmette-Guérin and mitomycin C for panurothelial carcinomatosis. 399
Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg: Results Of A Multicenter Retrospective Series In 2530 Patients 399
Intravesical sequential bacillus Calmette-Guérin and electromotive mitomycin versus bacillus Calmette-Guérin alone for stage pt1 urothelial bladder cancer 398
Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer 395
Malattia di La Peyronie. 395
Gender identity rather than sexual orientation impacts on facial preferences. 395
Valsalva leak point pressure 393
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction 389
Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience. 389
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis 387
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. 387
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass. 385
Defibrotide versus eparina calcica nella profilassi della trombosi venosa profonda in chirurgia urologica: studio randomizzato. 385
Transdermal electromotive administration of verapamil and dexametasone for Peyronie’s disease 384
Extracorporeal piezoelectric lithotripsy: experience in 930 patients. 383
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis. 382
Intravesical therapy with mitomycin through electromotive drug administration. 380
Single preoperative intravesical instillation of electromotive anitomycin-C for primary non-muscle-invasive bladder cancer: A prospective randonsied trial 380
Il drenaggio percutaneo ecoguidato transperineale delle raccolte pelviche 379
Intravesical Sequential BCG and Elecromotive Mitomycin-C versus BCG Alone for Stage pT1 Urothelial Bladder Cancer. 379
Long-term followup analysis of a randomized prospective study comparing intravesical electromotive mitomycin-C, passive diffusion mitomycin-C and bacillus Calmette-Guerin in patients with carcinoma in situ of the bladder. 378
Il ruolo dell'ecografia nello studio delle neoplasie della via escretrice superiore 377
Urodynamics in spinal cord injured patients walking with reciprocating gait orthosis. 373
Intralesional recombinant alpha 2a interferon therapy in superficial transitional cell carcinoma of the bladder 372
Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. 372
Totale 43.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021465 0 0 0 0 0 0 0 0 0 0 346 119
2021/20221.634 50 247 86 120 62 91 86 76 93 122 78 523
2022/20231.715 211 104 47 155 123 426 172 96 113 40 175 53
2023/2024782 70 41 83 47 51 93 90 46 43 45 22 151
2024/20254.080 163 993 454 191 80 346 207 132 258 313 506 437
2025/20265.821 503 261 837 404 535 311 844 675 709 735 7 0
Totale 66.075